Larsen Glenn R.

Director

Anika Therapeutics, Inc.

US, Bedford [HQ]

CIK 1633737

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

30,323

Price per Share :

$16.19

Equivalence :

$490,929.37

A

Form 4

30,323 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 06/14/23
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024.
A

Form 4

23,823 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 06/08/22
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023.
A

Form 4

36,094 Shares After Transaction

Value : $n/a

$0.0

Transaction Date : 07/09/24
- Footnotes
- Form 4
Footnotes:
#1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025.